RHEUMATIC DISEASE, ABNORMAL SEROLOGY, AND ORAL CONTRACEPTIVES
- 9 September 1972
- journal article
- Published by Elsevier in The Lancet
- Vol. 300 (7776) , 501-503
- https://doi.org/10.1016/s0140-6736(72)91903-4
Abstract
No abstract availableKeywords
Funding Information
- Arthritis Foundation
This publication has 11 references indexed in Scilit:
- Oral contraceptives and exacerbation of lupus erythematosusAmerican Journal of Obstetrics and Gynecology, 1971
- Antinuclear Antibodies, Rheumatoid Factor and c‐Reactive Protein in Serum of Normal Women Using Oral ContraceptivesArthritis & Rheumatism, 1971
- A histometric study of two estrogens: Ethinyl-estradiol and its 3-methyl-ether derivative (mestranol); Their comparative effect upon the growth of the human endometriumContraception, 1970
- A four year follow‐up of suspected rheumatoid arthritis: The Tecumseh, Michigan, community health studyArthritis & Rheumatism, 1969
- RHEUMATIC SYMPTOMS AND SEROLOGICAL ABNORMALITIES INDUCED BY ORAL CONTRACEPTIVESThe Lancet, 1969
- Rheumatic complaints of women using anti-ovulatory drugs: An evaluationJournal of Chronic Diseases, 1968
- L.E. CELLS AFTER ORAL CONTRACEPTIVESThe Lancet, 1968
- L.E. CELLS AFTER ORAL CONTRACEPTIVESThe Lancet, 1968
- Inhibition of ovulation by estrogensAmerican Journal of Obstetrics and Gynecology, 1967
- Gamma2, Gamma1A, and Gamma1M Antinuclear Factors in Human Sera*Journal of Clinical Investigation, 1964